{
  "pmcid": "12366013",
  "sha256": "802181492b2534ab00c1547a1c5a56bcdfc3db6140622b769bc3c70bed7ddb7b",
  "timestamp_utc": "2025-11-09T22:23:07.202421+00:00",
  "model_used": "gpt-4o",
  "readability": {
    "flesch_kincaid": 14.342965116279068,
    "reading_ease": 11.377703488372134,
    "word_count": 215
  },
  "consort_scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 1,
        "evidence": "Randomised Controlled Trial of Remimazolam vs. Propofol Anesthesia in Minor Hepatectomy"
      },
      "Trial_Design": {
        "score": 1,
        "evidence": "72 patients scheduled for elective minor hepatectomy were randomized 1:1"
      },
      "Participants": {
        "score": 2,
        "evidence": "Conducted at Fudan University Shanghai Cancer Center, 72 patients scheduled for elective minor hepatectomy"
      },
      "Intervention": {
        "score": 2,
        "evidence": "randomized 1:1 to receive either remimazolam (Group R) or propofol (Group P) anesthesia"
      },
      "Objective": {
        "score": 1,
        "evidence": "This randomised controlled trial evaluated the hemodynamic stability of remimazolam-based anesthesia compared to propofol-based anesthesia"
      },
      "Method_Outcome": {
        "score": 1,
        "evidence": "The primary outcome was the hemodynamic instability score (HI-score)"
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Randomization was performed using MinimPy2 software, with allocation concealment ensured"
      },
      "Blinding": {
        "score": 2,
        "evidence": "Blinding was applied to outcome assessors and data entry personnel"
      },
      "Number_Randomised": {
        "score": 1,
        "evidence": "72 patients scheduled for elective minor hepatectomy were randomized 1:1"
      },
      "Number_Analysed": {
        "score": 1,
        "evidence": "66 patients were analyzed (33 per group) using a per-protocol approach"
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "Group R exhibited significantly lower total HI-scores (22.8 ± 2.1) compared to Group P (33.0 ± 4.1, p = 0.029)"
      },
      "Harms": {
        "score": 1,
        "evidence": "No significant differences in major cardiovascular events or hospital stay were observed"
      },
      "Trial_Registration": {
        "score": 1,
        "evidence": "ClinicalTrials.gov NCT06565715"
      },
      "Funding": {
        "score": 0,
        "evidence": "Funding: Not specified"
      }
    },
    "total_score": 18,
    "max_score": 25
  }
}